{"retracted":false,"update":{"timestamp":1448928000000,"doi":"10.1212/nxi.0000000000000189","type":"correction"},"doi":"10.1212/nxi.0000000000000179","journal":"Neurology - Neuroimmunology Neuroinflammation","publisher":"Ovid Technologies (Wolters Kluwer Health)","title":"Glatiramer acetate treatment negatively regulates type I interferon signaling"}
